Search Orphan Drug Designations and Approvals
-
Generic Name: | elamipretide |
---|---|
Date Designated: | 03/22/2022 |
Orphan Designation: | Treatment of Friedreich’s ataxia (FRDA) |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Stealth Biotherapeutics, Inc. 275 Grove Street, Suite 3-107 Newton, Massachusetts 02466 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-